DOCSLIB.ORG

Assembly Lecture 11 Biology W3310/4310 Virology Spring 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Assembly Lecture 11 Biology W3310/4310 Virology Spring 2014 “Anatomy is des.ny.” --SIGMUND FREUD All virions complete a common set of assembly reac3ons * common to all viruses common to many viruses ©Principles of Virology, ASM Press The structure of a virus parcle determines how it is formed ©Principles of Virology, ASM Press Assembly is dependent on host cell machinery • Cellular chaperones • Transport systems • Secretory pathway • Nuclear import and export machinery Concentrang components for assembly: Nothing happens fast in dilute solu1ons • Viral components oSen visible by light microscopy (‘factories’ or ‘inclusions’) • Concentrate proteins on internal membranes (poliovirus) • Negri bodies (rabies virus) Viral proteins have ‘addresses’ built into their structure • Membrane targeYng: Signal sequences, fa\y acid modificaons • Membrane retenYon signals • Nuclear localizaYon sequences (NLS) • Nuclear export signals 414 Localiza3on of viral proteins to the nucleus CHAPTER 12 Golgi apparatus Ribosome Rough endoplasmic reticulum Plasma membrane Py(VP1) + VP2/3 Ad hexon + 5 100 kDa Nuclear envelope: Outer nuclear membrane Inner nuclear membrane Nucleus Nuclear pore complex Mitochondrion Cytoskeleton: Influenza virus NP Intermediate filament Microtubule Actin filament bundle Extracellular matrix ©Principles of Virology, ASM Press Figure 12.1 Localization of viral proteins to the nucleus. The nucleus and major membrane-bound compartments of the cytoplasm, as well as components of the cytoskeleton, are illustrated schematically and not to scale. Viral proteins destined for the nucleus are synthesized by cytoplasmic polyribosomes, as illustrated for the infl uenza virus NP protein. They engage with the cytoplasmic face of the nuclear pore complex and are translocated into the nucleus by the protein import machinery of the host cell. Some viral structural proteins enter the nucleus as preassembled structural units (polyomaviral [Py] VP1 pentamers associated with one molecule of either VP2 or VP3) or in association with a viral chaperone (adenoviral [Ad] hexon monomers bound to the L4 100-kDa protein). polyomaviruses, must enter the nucleus despite continual Assembly of the heteromeric complex facilitates import of transport of cellular proteins. Whether import of viral pro- the minor structural proteins, even though each contains teins is favored in such circumstances, for example, by the a nuclear localization signal. The increased density of these presence of particularly effective nuclear localization sig- signals may allow more effective competition for essential nals, is not known. components of the import pathway, or the nuclear local- Many viral structural proteins that enter infected cell ization signals may be more accessible in the complex. nuclei form multimeric capsid components. In some cases, Despite such potential advantages as increased effi - structural units of the virion are assembled in the cyto- ciency of import of viral proteins and transport of the struc- plasm prior to import into the nucleus. Pentamers of the tural proteins in the appropriate stoichiometry, import of major capsid protein (VP1) of simian virus 40 and poly- preassembled capsid components is not universal. For omavirus specifi cally bind a monomer of either VP2 or example, adenoviral hexons, which are trimers of viral VP3, the minor virion proteins, which share C-terminal protein II, are found only in the nucleus of the infected sequences (Appendix, Fig. 15B). Such heteromeric assem- cell. Association of newly synthesized hexon monomers blies are the substrates for import into the nucleus. Indeed, with a late, nonstructural protein, the L4 100-kDa protein, effi cient nuclear localization of polyomavirus VP2 and VP3 is essential for both the entry of hexon subunits into the proteins occurs only in cells in which VP1 is also made. nucleus and their assembly into trimers. The monomeric AASM-FLINT-08-0601-C012.inddSM-FLINT-08-0601-C012.indd 441414 99/12/08/12/08 44:58:00:58:00 PPMM Intracellular Traffi cking 415 hexon-L4 protein complex must be the import substrate. Transport of Viral Membrane Proteins The viral L4 100-kDa protein might supply the nuclear to the Plasma Membrane localization signal for hexon import, or promote nuclear Viral membrane proteins reach their destinations by the retention, by facilitating assembly of hexon trimers within highly conserved, cellular secretory pathway. Many of the nucleus. the steps in the pathway have been studied by using viral membrane glycoproteins, such as the vesicular stomatitis Assembly at the Plasma Membrane virus G and infl uenza virus hemagglutinin (HA) proteins. Assembly of enveloped viruses frequently takes place at the These viral proteins offer several experimental advantages: plasma membrane of infected cells (Table 12.1). Before such they are frequently synthesized in large quantities, their virions can form, viral integral membrane proteins must be synthesis is initiated in a controlled fashion following infec- transported to this cellular membrane (Fig. 12.2). The fi rst tion, and their transport can be studied readily by genetic, stages of the pathway by which viral and cellular proteins biochemical, and imaging methods. are delivered to the plasma membrane were identifi ed more Entry into the fi rst staging post of the secretory path- than 30 years ago, and the process is now quite well under- way, the endoplasmic reticulum (ER), is accompanied by stood. Viruses with envelopes derived from the plasma membrane insertion of integral membrane proteins. Viral membrane also contain internal proteins, which may be envelope proteins generally span the cellular membrane membrane associated, and, of course, nucleic acid genomes. into which they are inserted only once, and therefore con- These internal components must also be sorted to appropri- tain a single transmembrane domain. In viral proteins, ate plasma membrane sites for assembly (Fig. 12.2). transmembrane segments (described in Chapter 5) usually Figure 12.2 Localization of viral proteins to the plasma membrane. Viral envelope glycoproteins (red) are cotranslationally translocated into the ER lumen and folded and assembled within that compartment. They travel via transport vesicles to and through the Golgi apparatus and from the Golgi apparatus to the Localiza3on of viral proteins to plasma membraneplasma membrane. The internal proteins of the particle (purple) and the genome (green) are also directed to plasma membrane sites of assembly. Other viral Viral RNA Nascent viral protein proteins Cell surface viral protein Golgi Fusion Nucleus Transport vesicle Mitochondrion Microtubule ER Cytoskeleton Extracellular matrix ©Principles of Virology, ASM Press AASM-FLINT-08-0601-C012.inddSM-FLINT-08-0601-C012.indd 441515 99/12/08/12/08 44:58:00:58:00 PPMM Three strategies for making sub-assemblies ©Principles of Virology, ASM Press viral chaperone ©Principles of Virology, ASM Press Sequen3al capsid assembly: Poliovirus ©Principles of Virology, ASM Press Assembly intermediates and the assembly-line concept • Ensure orderly formaon of viral parYcles and virion subunits • FormaYon of discrete intermediate structures • Can’t proceed unless previous structure is formed: quality control ©Principles of Virology, ASM Press {sequenYal} Viral scaffolding proteins • establish transient intermediate structures • viral proteases packaged in these intermediate structures become acYvated to finalize structure ©Principles of Virology, ASM Press Sequen3al Assembly Adenovirus genome packaged into a preformed shell in the nucleus ©Principles of Virology, ASM Press Self-assembly vs assisted assembly reacons • Self-assembly - Retrovirus gag, influenza HA, HBV surface form VLPs • Assisted assembly - Can’t assemble alone - Proteins and genomes required as scaffolds or chaperones to form structure Concerted Assembly Influenza virus parYcles form by budding ©Principles of Virology, ASM Press ©Principles of Virology, ASM Press ©Principles of Virology, ASM Press Genome packaging • Problem: Viral genomes must be disYnguished from cellular DNA or RNA molecules where assembly takes place • Soluon: Packaging signals in the viral genome Packaging signals - DNA genomes ! Adenovirus • Packaging signal near leS inverted repeat and origin • Signal is complex: a set of repeated sequences; overlapping with enhancers that sYmulate late transcripYon • Recognized by viral protein IV2a (also a transcripYonal acYvator) ©Principles of Virology, ASM Press •Herpesvirus genome replicaYon produces concatemers with head-to-tail copies of viral genome ! •HSV-1 packaging signals pac1 and pac2 needed for recogniYon of viral DNA and cleavage within DR1 ©Principles of Virology, ASM Press Packaging signals - RNA Necessary but not sufficient for HIV-1 genome packaging ©Principles of Virology, ASM Press Packaging signals - RNA genomes 350 nt env mRNAs not packaged ©Principles of Virology, ASM Press Packaging of segmented genomes • Random mechanism would yield 1 infecYous parYcle per 400 assembled - within known parYcle:pfu raYo • Evidence for specific packaging sequence on each RNA segment Influenza virus RNA packaging h\p://www.virology.ws/2009/06/26/packaging-of-the-segmented-influenza-rna-genome/ Selec3ve packaging • Bacteriophage ϕ6 - 3 dsRNA segments S, M, L • Serial dependence of packaging: S-M-L • ParYcle:pfu raYo ~1 Acquisi3on of an envelope • Aer assembly of internal structures (most enveloped viruses) • Simultaneous with assembly of internal structures (retroviruses) Four budding strategies Envelope Internal
Recommended publications
  • Herpes Simplex Virus Type 1 Oril Is Not Required for Virus Infection In

    Herpes Simplex Virus Type 1 Oril Is Not Required for Virus Infection In

    JOURNAL OF VIROLOGY, Nov. 1987, p. 3528-3535 Vol. 61, No. 11 0022-538X/87/113528-08$02.00/0 Copyright C 1987, American Society for Microbiology Herpes Simplex Virus Type 1 oriL Is Not Required for Virus Replication or for the Establishment and Reactivation of Latent Infection in Mice MARYELLEN POLVINO-BODNAR, PAULO K. ORBERG, AND PRISCILLA A. SCHAFFER* Laboratory of Tumor Virus Genetics, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 Received 11 May 1987/Accepted 31 July 1987 During the course of experiments designed to isolate deletion mutants of herpes simplex virus type 1 in the gene encoding the major DNA-binding protein, ICP8, a mutant, d61, that grew efficiently in ICP8-expressing Vero cells but not in normal Vero cells was isolated (P. K. Orberg and P. A. Schaffer, J. Virol. 61:1136-1146, 1987). d61 was derived by cotransfection of ICP8-expressing Vero cells with infectious wild-type viral DNA and a plasmid, pDX, that contains an engineered 780-base-pair (bp) deletion in the ICP8 gene, as well as a spontaneous -55-bp deletion in OriL. Gel electrophoresis and Southern blot analysis indicated that d61 DNA carried both deletions present in pDX. The ability of d61 to replicate despite the deletion in OriL suggested that a functional OriL is not essential for virus replication in vitro. Because d61 harbored two mutations, a second mutant, ts+7, with a deletion in oriL-associated sequences and an intact ICP8 gene was constructed. Both d61 and ts+7 replicated efficiently in their respective permissive host cells, although their yields were slightly lower than those of control viruses with intact oriL sequences.
  • Topological Analysis of the Gp41 MPER on Lipid Bilayers Relevant to the Metastable HIV-1 Envelope Prefusion State

    Topological Analysis of the Gp41 MPER on Lipid Bilayers Relevant to the Metastable HIV-1 Envelope Prefusion State

    Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state Yi Wanga,b, Pavanjeet Kaurc,d, Zhen-Yu J. Sune,1, Mostafa A. Elbahnasawya,b,2, Zahra Hayatic,d, Zhi-Song Qiaoa,b,3, Nhat N. Buic, Camila Chilea,b,4, Mahmoud L. Nasre,5, Gerhard Wagnere, Jia-Huai Wanga,f, Likai Songc, Ellis L. Reinherza,b,6, and Mikyung Kima,g,6 aLaboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; bDepartment of Medicine, Harvard Medical School, Boston, MA 02115; cNational High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32306; dDepartment of Physics, Florida State University, Tallahassee, FL 32306; eDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; fDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215; and gDepartment of Dermatology, Harvard Medical School, Boston, MA 02215 Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY, and approved September 23, 2019 (received for review July 18, 2019) The membrane proximal external region (MPER) of HIV-1 envelope immunologically vulnerable epitopes targeted by several of the most glycoprotein (gp) 41 is an attractive vaccine target for elicitation of broadly neutralizing antibodies (bNAbs) developed during the broadly neutralizing antibodies (bNAbs) by vaccination. However, course of natural HIV-1 infection (10–13). Insertion, deletion, current details regarding the quaternary structural organization of and mutations of residues in the MPER defined the functional the MPER within the native prefusion trimer [(gp120/41)3] are elu- importance of the MPER in Env incorporation, viral fusion, and sive and even contradictory, hindering rational MPER immunogen infectivity (14–16).
  • Viroporins: Structures and Functions Beyond Cell Membrane Permeabilization

    Viroporins: Structures and Functions Beyond Cell Membrane Permeabilization

    Editorial Viroporins: Structures and Functions beyond Cell Membrane Permeabilization José Luis Nieva 1,* and Luis Carrasco 2,* Received: 17 September 2015 ; Accepted: 21 September 2015 ; Published: 29 September 2015 Academic Editor: Eric O. Freed 1 Biophysics Unit (CSIC, UPV/EHU) and Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), P.O. Box 644, 48080 Bilbao, Spain 2 Centro de Biología Molecular Severo Ochoa (CSIC, UAM), c/Nicolás Cabrera, 1, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] (J.L.N.); [email protected] (L.C.); Tel.: +34-94-601-3353 (J.L.N.); +34-91-497-8450 (L.C.) Viroporins represent an interesting group of viral proteins that exhibit two sets of functions. First, they participate in several viral processes that are necessary for efficient production of virus progeny. Besides, viroporins interfere with a number of cellular functions, thus contributing to viral cytopathogenicity. Twenty years have elapsed from the first review on viroporins [1]; since then several reviews have covered the advances on viroporin structure and functioning [2–8]. This Special Issue updates and revises new emerging roles of viroporins, highlighting their potential use as antiviral targets and in vaccine development. Viroporin structure. Viroporins are usually short proteins with at least one hydrophobic amphipathic helix. Homo-oligomerization is achieved by helix–helix interactions in membranes rendering higher order structures, forming aqueous pores. Progress in viroporin structures during the last 2–3 years has in some instances provided a detailed knowledge of their functional architecture, including the fine definition of binding sites for effective inhibitors.
  • How Influenza Virus Uses Host Cell Pathways During Uncoating

    How Influenza Virus Uses Host Cell Pathways During Uncoating

    cells Review How Influenza Virus Uses Host Cell Pathways during Uncoating Etori Aguiar Moreira 1 , Yohei Yamauchi 2 and Patrick Matthias 1,3,* 1 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; [email protected] 2 Faculty of Life Sciences, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK; [email protected] 3 Faculty of Sciences, University of Basel, 4031 Basel, Switzerland * Correspondence: [email protected] Abstract: Influenza is a zoonotic respiratory disease of major public health interest due to its pan- demic potential, and a threat to animals and the human population. The influenza A virus genome consists of eight single-stranded RNA segments sequestered within a protein capsid and a lipid bilayer envelope. During host cell entry, cellular cues contribute to viral conformational changes that promote critical events such as fusion with late endosomes, capsid uncoating and viral genome release into the cytosol. In this focused review, we concisely describe the virus infection cycle and highlight the recent findings of host cell pathways and cytosolic proteins that assist influenza uncoating during host cell entry. Keywords: influenza; capsid uncoating; HDAC6; ubiquitin; EPS8; TNPO1; pandemic; M1; virus– host interaction Citation: Moreira, E.A.; Yamauchi, Y.; Matthias, P. How Influenza Virus Uses Host Cell Pathways during 1. Introduction Uncoating. Cells 2021, 10, 1722. Viruses are microscopic parasites that, unable to self-replicate, subvert a host cell https://doi.org/10.3390/ for their replication and propagation. Despite their apparent simplicity, they can cause cells10071722 severe diseases and even pose pandemic threats [1–3].
  • Ube1a Suppresses Herpes Simplex Virus-1 Replication

    Ube1a Suppresses Herpes Simplex Virus-1 Replication

    viruses Article UBE1a Suppresses Herpes Simplex Virus-1 Replication Marina Ikeda 1 , Akihiro Ito 2, Yuichi Sekine 1 and Masahiro Fujimuro 1,* 1 Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan; [email protected] (M.I.); [email protected] (Y.S.) 2 Laboratory of Cell Signaling, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-75-595-4717 Academic Editors: Magdalena Weidner-Glunde and Andrea Lipi´nska Received: 7 November 2020; Accepted: 1 December 2020; Published: 4 December 2020 Abstract: Herpes simplex virus-1 (HSV-1) is the causative agent of cold sores, keratitis, meningitis, and encephalitis. HSV-1-encoded ICP5, the major capsid protein, is essential for capsid assembly during viral replication. Ubiquitination is a post-translational modification that plays a critical role in the regulation of cellular events such as proteasomal degradation, protein trafficking, and the antiviral response and viral events such as the establishment of infection and viral replication. Ub-activating enzyme (E1, also named UBE1) is involved in the first step in the ubiquitination. However, it is still unknown whether UBE1 contributes to viral infection or the cellular antiviral response. Here, we found that UBE1a suppressed HSV-1 replication and contributed to the antiviral response. The UBE1a inhibitor PYR-41 increased HSV-1 production. Immunofluorescence analysis revealed that UBE1a highly expressing cells presented low ICP5 expression, and vice versa. UBE1a inhibition by PYR-41 and shRNA increased ICP5 expression in HSV-1-infected cells.
  • HSV-1 Single-Cell Analysis Reveals the Activation of Anti-Viral And

    HSV-1 Single-Cell Analysis Reveals the Activation of Anti-Viral And

    RESEARCH ARTICLE HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations Nir Drayman1,2*, Parthiv Patel1,2, Luke Vistain1,2, Savas¸Tay1,2* 1Institute for Molecular Engineering, The University of Chicago, Chicago, United States; 2Institute for Genomics and Systems Biology, The University of Chicago, Chicago, United States Abstract Viral infection is usually studied at the population level by averaging over millions of cells. However, infection at the single-cell level is highly heterogeneous, with most infected cells giving rise to no or few viral progeny while some cells produce thousands. Analysis of Herpes Simplex virus 1 (HSV-1) infection by population-averaged measurements has taught us a lot about the course of viral infection, but has also produced contradictory results, such as the concurrent activation and inhibition of type I interferon signaling during infection. Here, we combine live-cell imaging and single-cell RNA sequencing to characterize viral and host transcriptional heterogeneity during HSV-1 infection of primary human cells. We find extreme variability in the level of viral gene expression among individually infected cells and show that these cells cluster into transcriptionally distinct sub-populations. We find that anti-viral signaling is initiated in a rare group of abortively infected cells, while highly infected cells undergo cellular reprogramming to an embryonic-like transcriptional state. This reprogramming involves the recruitment of b-catenin to the host nucleus and viral replication compartments, and is required for late viral gene expression and progeny production. These findings uncover the transcriptional differences in cells with variable infection outcomes and shed new light on the manipulation of host pathways by HSV-1.
  • HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection

    HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection

    MICROBIOLOGICAL REVIEWS, Mar. 1995, p. 63–93 Vol. 59, No. 1 0146-0749/95/$04.0010 Copyright q 1995, American Society for Microbiology The Human Immunodeficiency Virus Type 1 (HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection STEPHANE BOUR,* ROMAS GELEZIUNAS,† AND MARK A. WAINBERG* McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital, and Departments of Microbiology and Medicine, McGill University, Montreal, Quebec, Canada H3T 1E2 INTRODUCTION .........................................................................................................................................................63 RETROVIRAL RECEPTORS .....................................................................................................................................64 Receptors for Animal Retroviruses ........................................................................................................................64 CD4 Is the Major Receptor for HIV-1 Infection..................................................................................................65 ROLE OF THE CD4 CORECEPTOR IN T-CELL ACTIVATION........................................................................65 Structural Features of the CD4 Coreceptor..........................................................................................................65 Interactions of CD4 with Class II MHC Determinants ......................................................................................66 CD4–T-Cell Receptor Interactions during T-Cell Activation
  • HIV-1 Env Gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Wa- Ter, and Ion Interactions

    HIV-1 Env Gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Wa- Ter, and Ion Interactions

    bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. HIV-1 Env gp41 Transmembrane Domain Dynamics are Modulated by Lipid, Wa- ter, and Ion Interactions L.R. Hollingsworth IV, J.A. Lemkul, D.R. Bevan, and A.M. Brown Running Title: gp41 trimer dynamics in a lipid membrane Keywords: molecular dynamics simulations, protein-membrane interactions, HIV-1 gp41, envelope glycoprotein 1 bioRxiv preprint doi: https://doi.org/10.1101/292326; this version posted March 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract The gp41 transmembrane domain (TMD) of the envelope glycoprotein (Env) of the human immunodeficiency virus (HIV) modulates the conformation of the viral enve- lope spike, the only druggable target on the surface of the virion. Understanding of TMD dynamics is needed to better probe and target Env with small molecule and antibody therapies. However, little is known about TMD dynamics due to difficulties in describing native membrane properties. Here, we performed atomistic molecular dynamics simula- tions of a trimeric, prefusion TMD in a model, asymmetric viral membrane that mimics the native viral envelope. We found that water and chloride ions permeated the mem- brane and interacted with the highly conserved arginine bundle, (R696)3, at the center of the membrane and influenced TMD stability by creating a network of hydrogen bonds and electrostatic interactions.
  • The SARS-Coronavirus Infection Cycle: a Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis

    The SARS-Coronavirus Infection Cycle: a Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis

    International Journal of Molecular Sciences Review The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis Nicholas A. Wong * and Milton H. Saier, Jr. * Department of Molecular Biology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0116, USA * Correspondence: [email protected] (N.A.W.); [email protected] (M.H.S.J.); Tel.: +1-650-763-6784 (N.A.W.); +1-858-534-4084 (M.H.S.J.) Abstract: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus disease 2019 (COVID- 19), a global health crisis. Other epidemic Betacoronaviruses include the 2003 SARS-CoV-1 and the 2009 Middle East Respiratory Syndrome Coronavirus (MERS-CoV), the genomes of which, particularly that of SARS-CoV-1, are similar to that of the 2019 SARS-CoV-2. In this extensive review, we document the most recent information on Coronavirus proteins, with emphasis on the membrane proteins in the Coronaviridae family. We include information on their structures, functions, and participation in pathogenesis. While the shared proteins among the different coronaviruses may vary in structure and function, they all seem to be multifunctional, a common theme interconnecting these viruses. Many transmembrane proteins encoded within the SARS-CoV-2 genome play important roles in the infection cycle while others have functions yet to be understood. We compare the various structural and nonstructural proteins within the Coronaviridae family to elucidate potential overlaps Citation: Wong, N.A.; Saier, M.H., Jr.
  • Superimposition of Viral Protein Structures: a Means to Decipher the Phylogenies of Viruses

    Superimposition of Viral Protein Structures: a Means to Decipher the Phylogenies of Viruses

    viruses Review Superimposition of Viral Protein Structures: A Means to Decipher the Phylogenies of Viruses Janne J. Ravantti 1 , Ane Martinez-Castillo 2 and Nicola G.A. Abrescia 2,3,4,* 1 Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, FI-00014 Helsinki, Finland; Janne.Ravantti@helsinki.fi 2 Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, 48160 Derio, Spain; [email protected] 3 IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain 4 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-946572502 Received: 10 September 2020; Accepted: 2 October 2020; Published: 9 October 2020 Abstract: Superimposition of protein structures is key in unravelling structural homology across proteins whose sequence similarity is lost. Structural comparison provides insights into protein function and evolution. Here, we review some of the original findings and thoughts that have led to the current established structure-based phylogeny of viruses: starting from the original observation that the major capsid proteins of plant and animal viruses possess similar folds, to the idea that each virus has an innate “self”. This latter idea fueled the conceptualization of the PRD1-adenovirus lineage whose members possess a major capsid protein (innate “self”) with a double jelly roll fold. Based on this approach, long-range viral evolutionary relationships can be detected allowing the virosphere to be classified in four structure-based lineages. However, this process is not without its challenges or limitations.
  • Viral Surface Glycoproteins, Gp120 and Gp41, As Potential Drug Targets

    Viral Surface Glycoproteins, Gp120 and Gp41, As Potential Drug Targets

    European Journal of Medicinal Chemistry 46 (2011) 979e992 Contents lists available at ScienceDirect European Journal of Medicinal Chemistry journal homepage: http://www.elsevier.com/locate/ejmech Invited review Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug Cátia Teixeira a,b,c, José R.B. Gomes b, Paula Gomes c,*, François Maurel a a ITODYS, Université Paris Diderot, CNRS e UMR7086, 15 Rue Jean Antoine de Baif, 75205 Paris Cedex 13, France b CICECO, Universidade de Aveiro, Campus Universitário de Santiago, P-3810-193 Aveiro, Portugal c Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. Campo Alegre, 687, P-4169-007 Porto, Portugal article info abstract Article history: The first anti-HIV drug, zidovudine (AZT), was approved by the FDA a quarter of a century ago, in 1985. Received 22 September 2010 Currently, anti-HIV drug-combination therapies only target HIV-1 protease and reverse transcriptase. Received in revised form Unfortunately, most of these molecules present numerous shortcomings such as viral resistances and 15 January 2011 adverse effects. In addition, these drugs are involved in later stages of infection. Thus, it is necessary to Accepted 25 January 2011 develop new drugs that are able to block the first steps of viral life cycle. Entry of HIV-1 is mediated by its Available online 3 February 2011 two envelope glycoproteins: gp120 and gp41. Upon gp120 binding to cellular receptors, gp41 undergoes a series of conformational changes from a non-fusogenic to a fusogenic conformation.
  • Cell-Surface Receptors for Retroviruses and Implications for Gene Transfer A

    Cell-Surface Receptors for Retroviruses and Implications for Gene Transfer A

    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 11407-11413, October 1996 Colloquium Paper This paper was presented at a colloquium entitled "Genetic Engineering of Viruses and of Virus Vectors," organized by Bernard Roizman and Peter Palese (Co-chairs), held June 9-11, 1996, at the National Academy ofSciences in Irvine, CA Cell-surface receptors for retroviruses and implications for gene transfer A. DUSTY MILLER Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Room C2-023, Seattle, WA 98109 ABSTRACT Retroviruses can utilize a variety of cell- occurring retroviruses can use a variety of different proteins surface proteins for binding and entry into cells, and the for cell entry, although in general individual retroviruses cloning of several of these viral receptors has allowed refine- appear to recognize- a single receptor. Utilization of addi- ment of models to explain retrovirus tropism. A single recep- tional cell-surface proteins for vector entry has been tor appears to be necessary and sufficient for entry of many achieved by incorporation of polypeptides into the Env retroviruses, but exceptions to this simple model are accu- protein to alter its receptor binding properties or by replace- mulating. For example, HIV requires two proteins for cell ment of the retroviral Env protein with surface proteins from entry, neither of which alone is sufficient; lOAl murine other viruses. These alterations can allow targeting of par- leukemia virus can enter cells by using either of two distinct ticular cells that express specific proteins or an expansion of receptors; two retroviruses can use different receptors in some the range of cells that can be transduced by targeting broadly cells but use the same receptor for entry into other cells; and expressed proteins.